AI for Earlier Neurological Risk Detection at PMFG Summit 2025
At PMFG Summit 2025: Precision Medicine and the Future of Genomics, one idea stayed with us: the story of one child can become a roadmap of hope for millions.
The “Mila to Millions” journey was a powerful reminder of what becomes possible when genomics, clinical research, and AI work together. Medicine is moving beyond one-size-fits-all approaches. It is becoming more personalized, more data-driven, and more capable of identifying patterns that may be difficult to detect through human observation alone.
For TechPreneur, this is where AI can create some of its most meaningful impact.
Sharing Our Work in AI-Powered EEG Analysis
TechPreneur was proud to stand in the Digital Incubation Center pavilion and share our work with Dr. Samir B. Belhaouari on AI-powered EEG analysis for early neurological risk detection.
This work reflects a clear and ambitious vision: to help clinicians detect risk earlier, support more informed decision-making, and give families the gift of time.
In healthcare, time matters deeply. Earlier detection can create more space to respond, plan, treat, and support families through complex medical journeys.
Building Meaningful Healthcare AI in Qatar
PMFG 2025 highlighted the role Qatar can play in bringing together research, care, and innovation. It also reinforced the importance of building AI that is practical, accessible, and aligned with real clinical needs.
At TechPreneur, we believe advanced AI should not stay limited to research concepts or isolated experiments. It should become part of meaningful healthcare solutions that can support clinicians, improve outcomes, and help families access better guidance when it matters most.
A Responsibility to Build With Purpose
We are grateful to Sidra Medicine for hosting an inspiring summit that brought together important conversations on genomics, precision medicine, and the future of care. We also extend our thanks to Dr. Ammira Al-Shabeeb AKIL for her continued support.
For us, PMFG 2025 was a reminder of our responsibility as an AI company: to turn powerful technologies into tools that serve people.
Our goal is to contribute to a future where AI helps identify risk earlier, supports better clinical pathways, and creates hope for the next “Mila” and the millions after her.